Yesterday in Boston, President Biden presented a 25-minute speech detailing his “Cancer Moonshot” goal of a 50 percent cancer reduction within 25 years. Although it should be entirely doable, with 80% of lung cancers and 30 percent of all cancer deaths being nicotine-driven, all segments of the nicotine industry will be working against it.

Take, for example, the cleanest form of nicotine delivery, NRT or nicotine replacement therapy. Despite eleven 2022 studies detailing how the nicotine molecule promotes the growth and metastasis of cancer, the National Cancer Institute (NCI) continues funding studies involving replacement nicotine use by smokers most at risk of being diagnosed with cancer.

It gets worse. Despite nearly all population-level effectiveness findings over the past 20 years indicating that NRT undercuts successful quitting, the NCI continues to champion it.

What hope is there for the President's "Cancer Moonshot" if America’s cancer guardian insists on promoting cancer?

---

John R. Polito received his JD from the University of South Carolina School of Law in 1985, where he graduated Wig & Robe. He is a former 3-pack-a-day thirty-year smoker and the 1999 founder of WhyQuit. A nicotine cessation educator since 2000, John mentored under Joel Spitzer for two decades, presenting more than 100 live nicotine dependency recovery programs modeled after Joel's programs. He is the author of "Freedom from Nicotine - The Journey Home," "Smart Turkey," and 6 peer-reviewed journal articles. John is the founder and director of Turkeyville, a 15,000-member Facebook support group exclusively for cold turkey quitters. Email: johnpolito54@gmail.com

---

---